• Sun Pharma reported 5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended December (Q3FY22). On a year-on-year (YoY) basis, it witnessed a growth of 12%.
  • Its expenses for the quarter were up 4% QoQ and 12% YoY.
  • While the company reported a net profit of 2% QoQ, the same grew by 11% on a YoY basis.
  • The earnings per share (EPS) of Sun Pharma stood at 8.6 during Q3FY22.

Sun Pharma Financial Statements for Q3FY22:

(Rs, crores) Q3FY21 Q2FY22 Q3FY22 QoQ (%) YoY (%)
Total Income 9,152 9,849 10,296 5% 12%
Total Expenses 6,989 7,562 7,829 4% 12%
Profit before tax 2,163 2,287 2,466 8% 14%
Tax 245 198 335 70% 37%
Profit after tax 1,913 2,086 2,126 2% 11%
Earnings per share 7.7 8.5 8.6     

Data Source: BSE, Company announcements

Want to get more analysis on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results